0002013412-24-000003.txt : 20240311 0002013412-24-000003.hdr.sgml : 20240311 20240311163355 ACCESSION NUMBER: 0002013412-24-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sousa Ben CENTRAL INDEX KEY: 0002013412 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 24738559 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC. STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-03-07 0 0000883984 ICU MEDICAL INC/DE ICUI 0002013412 Sousa Ben 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Chief Information Officer 0 Common Stock 2024-03-07 4 M 0 429 0.0 A 552 D Common Stock 2024-03-07 4 F 0 159 105.39 D 393 D Common Stock 2024-03-07 4 M 0 2574 0.0 A 2967 D Common Stock 2024-03-07 4 F 0 918 105.39 D 2049 D Common Stock 2024-03-08 4 M 0 674 0.0 A 2723 D Common Stock 2024-03-08 4 F 0 240 104.52 D 2483 D Common Stock 0.0 2024-03-08 4 M 0 674 0.0 D 2024-03-08 Common Stock 674 0 D Common Stock 0.0 2024-03-07 4 M 0 429 0.0 D 2025-03-07 Common Stock 429 430 D Common Stock 2024-03-08 4 A 0 2871 0.0 A Common Stock 2871 2871 D Performance Shares 0.0 2024-03-07 4 M 0 2574 0.0 D 2024-03-07 Common Stock 2574 0 D These securities are Restricted Stock Units. These Securities are Performance-based Restricted Stock Units (PRSU). There is neither a purchase price nor an exercise price for the Restricted Stock Units. One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These are restricted stock units that fully vest 3 years from the grant date. There is neither a purchase price nor an exercise price for the PRSUs. These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant. By: Paula Darbyshire, Attorney-in-fact For: Benjamin Sousa 2024-03-11